DyDo Group Holdings, Inc. engages in the production and sale of beverages. It operates through the following segments: Domestic and Overseas Beverage, Pharmaceutical-Related, Food and Rare Disease Drug Business. The Domestic and Overseas Beverage Business segment engaged in the contract manufacturing, purchasing, and sales of beverages (coffee, tea, fruit juice, carbonated drinks, mineral water, sports drinks, energy drinks, and other beverage products). The Pharmaceutical-Related Business segment engages in the contract manufacturing of energy drinks. The Food Business segment manufactures and sells fruit jellies. The Rare Disease Drugs Business segment involves concluding license agreements for the manufacture and sale of rare disease drugs and conducting clinical trials. The Other segment includes pharmaceutical for rare disease treatment business. The company was founded by Tomio Takamatsu on January 27, 1975 and is headquartered in Osaka, Japan.